Nemus Bioscience, Inc.·4

Oct 12, 1:05 PM ET

DHILLON AVTAR S 4

4 · Nemus Bioscience, Inc. · Filed Oct 12, 2018

Insider Transaction Report

Form 4
Period: 2018-10-10
Transactions
  • Award

    Director Stock Option (Right to Buy)

    2018-10-10+1,000,0001,000,000 total
    Exercise: $0.30Exp: 2028-10-10Common Stock (1,000,000 underlying)
Footnotes (1)
  • [F1]The option will vest in equal monthly installments over a one-year period commencing on the date of grant.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION